SCHEMBL8670883

SCHEMBL8670883

Cc1c(O)cccc1C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
GAA P10253 1/20 0.40
CCR1 P32246 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
BACE1 P56817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8672247 0.87 CCR1 (0.42) NPC1RAB9ACCR1BACE1
SCHEMBL8668860 0.77 ATM (0.49) BACE1
SCHEMBL6929977 0.76 HPGDS (0.52) ALDH1A1CCR1BACE1
SCHEMBL7382779 0.76 ALDH1A1 (0.64) MAPK1SMN1; SMN2ALDH1A1HPGDLMNA
SCHEMBL8669429 0.76 PSMB5 (0.44) CCR1BACE1
Hydrochloric Acid SCHEMBL8897869 0.75 CCR1 (0.43) MAPK1SMN1; SMN2ALDH1A1CCR1CYP1A2
Hydrochloric Acid SCHEMBL8667609 0.75 PSMB5 (0.43) CCR1BACE1
SCHEMBL6927619 0.74 CTRB1 (0.50) NPC1RAB9ACCR1BACE1
SCHEMBL8673190 0.73 CYP3A4 (0.54) MAPK1ALDH1A1MEN1KMT2ACCR1
SCHEMBL5699585 0.72 PYGL (0.47) ALDH1A1HPGDLMNACYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5763464-A TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1998-06-09 US disclosed
WO-1997019061-A1 RETROVIRAL AGENTS CONTAINING ANTHRANILAMIDE, SUBSTITUTED BENZAMIDE AND OTHER SUBUNITS, AND METHODS OF USING SAME THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-05-29 WO disclosed